These compounds may interact with:
Gastrin/cholecystokinin type B receptor
Potentially involved in: carcinoma; large intestine cancer; panic disorder; pain agnosia; cancer; opiate dependence; agoraphobia; gastritis; hyperalgesia; obsessive-compulsive disorder; substance withdrawal syndrome; cocaine-related disorders; adult high grade glioma; astrocytic glioma; astrocytoma, pilocytic; atypical teratoid / rhabdoid tumor; cutaneous lupus erythematosus; down syndrome; ependymoma; glioblastoma
Disease data sourced from Pharos.